Detection of Polyethylene Glycol Thyrotropin (TSH) Precipitable Percentage (Macro-TSH) in Patients with a History of Thyroid Cancer

Overview

Journal Endocrinol Metab (Seoul)

Specialty Endocrinology

Date 2017 Dec 23

PMID 29271618

Citations 3

Authors

Massimo Giusti

Lucia Conte

Anna Maria Repetto

Stefano Gay

Paola Marroni

Miranda Mittica

Michele Mussap

Affiliations

Soon will be listed here.

Abstract

Background: Owing to its large molecular size, polyethylene glycol (PEG)-precipitable thyrotropin (TSH) can accumulate in the circulation, elevating TSH levels. PEG-precipitable TSH can be used to detect macro-TSH (mTSH) in serum. Our aim was to evaluate the prevalence of mTSH in patients who had undergone thyroidectomy for thyroid cancer.

Methods: Seventy-three thyroid cancer patients and 24 control subjects on levothyroxine (LT4) TSH-suppressive or replacement therapy were evaluated. Screening for mTSH was performed by adding PEG to serum in order to precipitate γ-globulin. A percentage of PEG-precipitable TSH ≥80% was considered suggestive of mTSH.

Results: No correlation between free-T4 (fT4) and TSH levels was found. PEG-precipitable TSH was 39.3%±1.9% in thyroid cancer patients and 44.1%±3.9% in controls. Macro-TSH was deemed to be present in one thyroid cancer patient and in two control subjects. Only in the thyroid cancer group was PEG-precipitable TSH found to be negatively correlated with fT4 concentration. No correlation was found between PEG-precipitable TSH and other clinical conditions in any patients.

Conclusion: The presence of mTSH seems to be a rare phenomenon in thyroid cancer. In some patients with low PEG-precipitable TSH, a reduction in LT4 dosage could be suggested. LT4 dosage adjusted to body weight is the main factor in maintaining TSH in a semi-suppressed or normal range. Evaluation of mTSH could be necessary in patients in whom a balance is required between adequate TSH suppression and the avoidance of unnecessary exogenous hyperthyroxinemia.

Citing Articles

PEG Precipitation to Detect Macro-TSH in Clinical Practice: A Systematic Review.

Piticchio T, Chiardi I, Tumminia A, Frasca F, Rotondi M, Trimboli P Clin Endocrinol (Oxf). 2024; 102(3):235-244.

PMID: 39702982 PMC: 11788973. DOI: 10.1111/cen.15179.

Pars Distalis and Pars Tuberalis Thyroid-Stimulating Hormones and Their Roles in Macro-Thyroid-Stimulating Hormone Formation.

Frohlich E, Wahl R Int J Mol Sci. 2023; 24(14).

PMID: 37511458 PMC: 10380753. DOI: 10.3390/ijms241411699.

A comparative cross-sectional study on sleep quality in patients with a history of differentiated thyroid carcinoma and its correlation with quality of life.

Teliti M, Monti E, Comina M, Conte L, Vera L, Gay S Endocrine. 2021; 73(2):347-357.

PMID: 33537955 PMC: 8263451. DOI: 10.1007/s12020-020-02591-z.

Neuroendocrine neoplasms - think about it and choose the most appropriate diagnostic and therapeutic steps.

Koch C, Petersenn S Rev Endocr Metab Disord. 2018; 19(2):107-109.

PMID: 30357544 DOI: 10.1007/s11154-018-9472-1.

References

Rix M, Laurberg P, Porzig C, Kristensen S . Elevated thyroid-stimulating hormone level in a euthyroid neonate caused by macro thyrotropin-IgG complex. Acta Paediatr. 2011; 100(9):e135-7. DOI: 10.1111/j.1651-2227.2011.02212.x. View

Padwal R, Brocks D, Sharma A . A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev. 2009; 11(1):41-50. DOI: 10.1111/j.1467-789X.2009.00614.x. View

Giusti M, Mortara L, Machello N, Monti E, Pera G, Marenzana M . Utility of a Liquid Formulation of Levo-thyroxine in Differentiated Thyroid Cancer Patients. Drug Res (Stuttg). 2014; 65(6):332-6. DOI: 10.1055/s-0034-1384535. View

Alexander E, Pearce E, Brent G, Brown R, Chen H, Dosiou C . 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017; 27(3):315-389. DOI: 10.1089/thy.2016.0457. View

Lam E, Strugnell S, Bajdik C, Holmes D, Wiseman S . Limited adequacy of thyroid cancer patient follow-up at a Canadian tertiary care centre. Can J Surg. 2013; 56(6):385-92. PMC: 3859780. DOI: 10.1503/cjs.018112. View

Ismail A, Walker P, Barth J, Lewandowski K, Jones R, Burr W . Wrong biochemistry results: two case reports and observational study in 5310 patients on potentially misleading thyroid-stimulating hormone and gonadotropin immunoassay results. Clin Chem. 2002; 48(11):2023-9. View

Del Duca S, Santaguida M, Brusca N, Gatto I, Cellini M, Gargano L . Individually-tailored thyroxine requirement in the same patients before and after thyroidectomy: a longitudinal study. Eur J Endocrinol. 2015; 173(3):351-7. DOI: 10.1530/EJE-15-0314. View

Smith T, Suliman A, Fahie-Wilson M, McKenna T . Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab. 2002; 87(12):5410-5. DOI: 10.1210/jc.2001-011943. View

Mills F, Jeffery J, Mackenzie P, Cranfield A, Ayling R . An immunoglobulin G complexed form of thyroid-stimulating hormone (macro thyroid-stimulating hormone) is a cause of elevated serum thyroid-stimulating hormone concentration. Ann Clin Biochem. 2013; 50(Pt 5):416-20. DOI: 10.1177/0004563213476271. View

10.

Samson S, Hamrahian A, Ezzat S . AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: CLINICAL RELEVANCE OF MACROPROLACTIN IN THE ABSENCE OR PRESENCE OF TRUE HYPERPROLACTINEMIA. Endocr Pract. 2015; 21(12):1427-35. DOI: 10.4158/EP15938.DSC. View

11.

Canaris G, Manowitz N, Mayor G, Ridgway E . The Colorado thyroid disease prevalence study. Arch Intern Med. 2000; 160(4):526-34. DOI: 10.1001/archinte.160.4.526. View

12.

Kricka L . Human anti-animal antibody interferences in immunological assays. Clin Chem. 1999; 45(7):942-56. View

13.

Loh T, Kao S, Halsall D, Toh S, Chan E, Ho S . Macro-thyrotropin: a case report and review of literature. J Clin Endocrinol Metab. 2012; 97(6):1823-8. DOI: 10.1210/jc.2011-3490. View

14.

Hattori N, Ishihara T, Yamagami K, Shimatsu A . Macro TSH in patients with subclinical hypothyroidism. Clin Endocrinol (Oxf). 2014; 83(6):923-30. DOI: 10.1111/cen.12643. View

15.

Haugen B, Alexander E, Bible K, Doherty G, Mandel S, Nikiforov Y . 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015; 26(1):1-133. PMC: 4739132. DOI: 10.1089/thy.2015.0020. View

16.

Skelin M, Lucijanic T, Amidzic Klaric D, Resic A, Bakula M, Liberati-cizmek A . Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review. Clin Ther. 2017; 39(2):378-403. DOI: 10.1016/j.clinthera.2017.01.005. View

17.

Gurnell M, Halsall D, Chatterjee V . What should be done when thyroid function tests do not make sense?. Clin Endocrinol (Oxf). 2011; 74(6):673-8. DOI: 10.1111/j.1365-2265.2011.04023.x. View

18.

Sukumar R, Agarwal A, Gupta S, Mishra A, Agarwal G, Verma A . Prediction of LT4 replacement dose to achieve euthyroidism in subjects undergoing total thyroidectomy for benign thyroid disorders. World J Surg. 2010; 34(3):527-31. DOI: 10.1007/s00268-009-0345-3. View

19.

Hattori N, Ishihara T, Shimatsu A . Variability in the detection of macro TSH in different immunoassay systems. Eur J Endocrinol. 2015; 174(1):9-15. DOI: 10.1530/EJE-15-0883. View

20.

Santini F, Pinchera A, Marsili A, Ceccarini G, Castagna M, Valeriano R . Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J Clin Endocrinol Metab. 2004; 90(1):124-7. DOI: 10.1210/jc.2004-1306. View